When Casey DeSantis, the first lady of Florida, recently disclosed how the state would distribute $60 million for cancer ...

While Natera said it will seek FDA approval for Signatera based on data from IMvigor011, the readout from another ctDNA-guided de-escalation study was more nuanced.

When pembrolizumab was added to paclitaxel with or without bevacizumab in platinum-resistant ovarian cancer, significant ...

(UroToday.com) The 2025 European Society for Medical Oncology (ESMO) Annual Congress was host to a radioligand therapeutics proffered paper session. Dr. Karolien Goffin discussed the previously ...

SciTech Development, Inc., a clinical-stage oncology company advancing nanotechnology-enabled cancer therapeutics, today ...

AstraZeneca and Daiichi Sankyo are challenging Gilead Sciences for dominance in one of the toughest-to-treat breast cancers in a race for patients — and profits.

In a boost to medical education in Jammu and Kashmir, the National Medical Commission (NMC) has recently approved a total of ...

Findings presented at European Society for Medical Oncology include models in solid tumors and hematologic malignancies ...

GT Medical Technologies, a company focused on improving the lives of patients with brain tumors, today announced the interim results from its ROADS clinical trial (Randomized Controlled Trial of ...

Therapeutics announced the addition of several key large cancer centers to its ongoing pivotal Phase 3 clinical study, notably ...

India’s cancer care sector, valued at Rs 1.25 lakh crore and growing 10–12% annually, is attracting significant private ...